JP2009520695A5 - - Google Patents

Download PDF

Info

Publication number
JP2009520695A5
JP2009520695A5 JP2008545125A JP2008545125A JP2009520695A5 JP 2009520695 A5 JP2009520695 A5 JP 2009520695A5 JP 2008545125 A JP2008545125 A JP 2008545125A JP 2008545125 A JP2008545125 A JP 2008545125A JP 2009520695 A5 JP2009520695 A5 JP 2009520695A5
Authority
JP
Japan
Prior art keywords
compound according
group
solvate
hydrate
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008545125A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009520695A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2006/003549 external-priority patent/WO2007069020A2/en
Publication of JP2009520695A publication Critical patent/JP2009520695A/ja
Publication of JP2009520695A5 publication Critical patent/JP2009520695A5/ja
Pending legal-status Critical Current

Links

JP2008545125A 2005-12-15 2006-12-04 抗菌活性を有するn−ヒドロキシアミド誘導体 Pending JP2009520695A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75060005P 2005-12-15 2005-12-15
PCT/IB2006/003549 WO2007069020A2 (en) 2005-12-15 2006-12-04 N-hydroxyamide derivatives possessing antibacterial activity

Publications (2)

Publication Number Publication Date
JP2009520695A JP2009520695A (ja) 2009-05-28
JP2009520695A5 true JP2009520695A5 (enExample) 2010-01-28

Family

ID=38163279

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008545125A Pending JP2009520695A (ja) 2005-12-15 2006-12-04 抗菌活性を有するn−ヒドロキシアミド誘導体

Country Status (5)

Country Link
US (1) US8088804B2 (enExample)
EP (2) EP1963262A2 (enExample)
JP (1) JP2009520695A (enExample)
CA (1) CA2634005C (enExample)
WO (1) WO2007069020A2 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101011373B1 (ko) 2002-07-11 2011-01-28 비큐론 파마슈티컬스 인코포레이티드 항균작용을 갖는 n-히드록시아미드 유도체
EP2170814B1 (en) 2007-06-12 2016-08-17 Achaogen, Inc. Antibacterial agents
EP2234608A2 (en) 2007-12-11 2010-10-06 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties
JP5650642B2 (ja) * 2008-08-01 2015-01-07 バイオキシネス ファーマシューティカルズ, インコーポレイテッド メチオニンアナログおよびそれらを使用する方法
US8722686B2 (en) 2008-09-19 2014-05-13 Pfizer Inc. Hydroxamic acid derivatives useful as antibacterial agents
JP5746864B2 (ja) * 2008-11-19 2015-07-08 ポーラ化成工業株式会社 シワ改善剤
EP2488489A2 (en) * 2009-10-13 2012-08-22 Pfizer Inc. C-linked hydroxamic acid derivatives useful as antibacterial agents
CA2899583A1 (en) 2009-12-16 2011-06-23 Pfizer Inc. N-linked hydroxamic acid derivatives useful as antibacterial agents
TWI543961B (zh) 2010-04-20 2016-08-01 大正製藥股份有限公司 Novel hydroxamic acid derivatives
KR101593288B1 (ko) * 2011-03-07 2016-02-11 화이자 인코포레이티드 항균제로서 유용한 플루오로-피리디논 유도체
CN103492368A (zh) 2011-04-08 2014-01-01 辉瑞大药厂 用作抗菌剂的咪唑、吡唑和噻唑衍生物
AU2012238374B2 (en) 2011-04-08 2015-04-02 Pfizer Inc. Isoxazole derivatives useful as antibacterial agents
JP6006609B2 (ja) * 2011-10-19 2016-10-12 大正製薬株式会社 新規なヒドロキサム酸誘導体を含有する医薬
WO2013170165A1 (en) 2012-05-10 2013-11-14 Achaogen, Inc. Antibacterial agents
ES2728336T3 (es) 2013-03-15 2019-10-23 Fujifilm Toyama Chemical Co Ltd Nuevo derivado de ácido hidroxámico o sal del mismo
EP2883876A1 (en) 2013-12-16 2015-06-17 Actelion Pharmaceuticals Ltd. Stereoselective synthesis of substituted pyrrolidines
AU2015316401A1 (en) 2014-09-12 2017-04-06 Fujifilm Toyama Chemical Co., Ltd. Novel pharmaceutical composition containing hydroxamic acid derivative or salt thereof
RU2017112303A (ru) 2014-09-12 2018-10-12 Тояма Кемикал Ко., Лтд. Способ применения комбинации нового производного гидроксамовой кислоты и антибактериального вещества
CN108569991A (zh) * 2018-05-31 2018-09-25 常州制药厂有限公司 一种抗丙肝病毒药物关键中间体的制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4077998A (en) 1975-10-28 1978-03-07 Morton-Norwich Products, Inc. Phthaloyl amino acid hydroxamic acids
KR100332273B1 (ko) * 1995-07-26 2002-06-20 디. 제이. 우드, 스피겔 알렌 제이 엔-(아로일)글리신하이드록삼산유도체및이와관련된화합물
CA2235986C (en) * 1995-11-06 2006-09-12 University Of Pittsburgh Inhibitors of protein isoprenyl transferases
US6693123B2 (en) * 1995-11-06 2004-02-17 University Of Pittsburgh Inhibitors of protein isoprenyl transferases
US5925659A (en) 1996-05-07 1999-07-20 Merck & Co., Inc. Antibacterial agents
WO1999006340A2 (en) 1997-07-31 1999-02-11 The Procter & Gamble Company Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors
US6784173B2 (en) * 2001-06-15 2004-08-31 Hoffmann-La Roche Inc. Aromatic dicarboxylic acid derivatives
KR101011373B1 (ko) 2002-07-11 2011-01-28 비큐론 파마슈티컬스 인코포레이티드 항균작용을 갖는 n-히드록시아미드 유도체
AU2004204760C1 (en) * 2003-01-08 2010-08-19 Novartis Vaccines And Diagnostics, Inc. Antibacterial agents
US7208601B2 (en) 2003-08-08 2007-04-24 Mjalli Adnan M M Aryl and heteroaryl compounds, compositions, and methods of use
DE10348023A1 (de) * 2003-10-15 2005-05-19 Imtm Gmbh Neue Alanyl-Aminopeptidasen-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen
JP2008508348A (ja) * 2004-08-02 2008-03-21 ジェンメディカ・セラピューティックス・ソシエダッド・リミターダ 銅含有アミンオキシダーゼを阻害するための化合物およびその使用
WO2006040646A1 (en) 2004-10-14 2006-04-20 Pfizer, Inc. Benzimidazole or indole amides as inhibitors of pin1
US20100152188A1 (en) 2005-08-05 2010-06-17 Akella Satya Surya Visweswara Srinivas Novel Heterocyclic Compounds

Similar Documents

Publication Publication Date Title
JP2009520695A5 (enExample)
JP2010527913A5 (enExample)
JP2010524932A5 (enExample)
JP2010530881A5 (enExample)
WO2006039668B1 (en) 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis c infection
JP2006505543A5 (enExample)
JP2005523922A5 (enExample)
EP2546246A3 (en) Compounds and methods for the treatment or prevention of flavivirus infections
JP2013503846A5 (enExample)
JP2010530372A5 (enExample)
JP2006514012A5 (enExample)
JP2008510828A5 (enExample)
JP2008533191A5 (enExample)
JP2009536660A5 (enExample)
JP2003519676A5 (enExample)
JP2013507425A5 (enExample)
JP2011511075A5 (enExample)
IL165715A0 (en) 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof
JP2005053931A5 (enExample)
JP2013510178A5 (enExample)
EA200901241A1 (ru) Соединения для лечения гепатита с
JP2015522650A5 (enExample)
NO20090595L (no) Ny pyridazinforbindelse og anvendelse derav
JP2008526999A5 (enExample)
JP2011526283A5 (enExample)